• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮康唑对白血病患者抗真菌预防的局限性。

Limits of antifungal prophylaxis by ketoconazole in leukemic patients.

作者信息

Mazzoni A, Fiorentini C, Cevenini R, Nanetti A

出版信息

Chemioterapia. 1985 Aug;4(4):299-302.

PMID:4053215
Abstract

Serum ketoconazole levels in leukemic patients, subjected to ketoconazole prophylaxis, were determined by an agar diffusion assay. High individual variability of drug concentration was noted. In addition, the highest drug concentration observed was less than 1 microgram/ml in 5 out of 6 patients studied. The reliability of prophylaxis of airborne opportunistic fungal infections by ketoconazole seems, therefore, to be hampered, at least in leukemics, by the too low serum concentrations of the drug. The bioassay proved to be highly reproducible and accurate as well as easy and safe to perform.

摘要

通过琼脂扩散试验测定了接受酮康唑预防治疗的白血病患者的血清酮康唑水平。发现药物浓度存在高度个体差异。此外,在所研究的6名患者中,有5名患者观察到的最高药物浓度低于1微克/毫升。因此,至少在白血病患者中,酮康唑预防空气传播的机会性真菌感染的可靠性似乎受到药物血清浓度过低的阻碍。生物测定法被证明具有高度可重复性、准确性,且操作简便、安全。

相似文献

1
Limits of antifungal prophylaxis by ketoconazole in leukemic patients.酮康唑对白血病患者抗真菌预防的局限性。
Chemioterapia. 1985 Aug;4(4):299-302.
2
[Ketoconazole and antifungal prevention in leukemia. Pharmacokinetic study].[酮康唑与白血病的抗真菌预防。药代动力学研究]
G Ital Chemioter. 1984 Jan-Aug;31(1-2):163-8.
3
[Ketoconazole in the prevention of mycotic complications during cytostatic treatment of leukemias and lymphomas].[酮康唑在白血病和淋巴瘤细胞毒性治疗期间预防真菌并发症中的应用]
Vnitr Lek. 1985 Jun;31(6):567-71.
4
Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.免疫功能低下患者霉菌感染的预防:27份报告及出版物综述
Drugs Exp Clin Res. 1986;12(5):419-27.
5
Serum levels of ketoconazole in bone marrow transplanted patients.骨髓移植患者的血清酮康唑水平。
Nouv Rev Fr Hematol (1978). 1983;25(4):241-4.
6
[Prevention of fungal infections with ketoconazole in cancer patients receiving cytostatic therapy].
Mycoses. 1988 Jun;31(6):324-9.
7
Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
Arch Intern Med. 1984 Mar;144(3):549-51.
8
Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg/d and 400 mg/d doses.实体瘤患者接受积极免疫抑制治疗时的酮康唑预防。200毫克/天和400毫克/天剂量的开放随机对照比较。
S Afr Med J. 1985 Jun 29;67(26):1044-5.
9
[Present and future of antifungal prophylaxis in leukemic patients].
Ann Ist Super Sanita. 1987;23(4):743-5.
10
How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.如何改进急性白血病中性粒细胞减少成人患者抗真菌预防试验的设计。
Clin Infect Dis. 2004 Oct 15;39 Suppl 4:S181-4. doi: 10.1086/421954.